Advanced solid tumors Trials in Jinan, China
Conditions / Advanced solid tumors / Jinan, China
Clinical trials for Advanced solid tumors investigate a range of treatment strategies and patient populations.
34 total trials for this combination
Showing top 10 of 34 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06459973 | A Clinical Study of YL205 in Patients With Advanced Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT06394414 | A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT03544905 | Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33 | COMPLETED | PHASE1 |
| NCT06907043 | A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors. | RECRUITING | PHASE1/PHASE2 |
| NCT05914116 | A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT06792552 | A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT05904496 | A Study of BGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors | TERMINATED | PHASE1 |
| NCT06741644 | A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors | RECRUITING | — |
| NCT06799637 | Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments | RECRUITING | — |
| NCT07169994 | A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors | RECRUITING | PHASE1/PHASE2 |